ClinicalTrials.govpublic full text
Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma
melanoma, gd3 adc (pfizer pf-06688992), stage iii melanoma, stage iv melanoma, 17-165, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850027
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.